Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel T Starczynowski

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Blood|August 2, 2014
Errant innate immune signaling in del(5q) MDSDaniel T Starczynowski
Blood|October 1, 2020
HHEX expression drives AML developmentDaniel T Starczynowski
Haematologica|June 15, 2023
Are <i>DDX41</i> variants of unknown significance and pathogenic variants created equal?Zhuoer Xie, Daniel T Starczynowski
Cell Stem Cell|May 6, 2017
GMP-ing to Spatial Conclusions about Emergency and Leukemic MyelopoiesisMadeline Niederkorn, Daniel T Starczynowski
Cell Cycle (Georgetown, Tex.)|February 18, 2010
Deregulation of innate immune signaling in myelodysplastic syndromes is associated with deletion of chromosome arm 5qDaniel T Starczynowski, Aly Karsan
Hematology/Oncology Clinics of North America|April 3, 2010
Innate immune signaling in the myelodysplastic syndromesDaniel T Starczynowski, Aly Karsan
Molecular & Cellular Oncology|June 17, 2016
Genomic instability establishes dependencies on acquired gene regulatory networks: A novel role of p62 in myeloid malignancies with del(5q)Jing Fang, Daniel T Starczynowski
Current Opinion in Hematology|November 7, 2021
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignanciesJoshua Bennett, Daniel T Starczynowski
Expert Opinion on Investigational Drugs|October 10, 2025
IRAK signaling in cancers: mechanisms, targeting, and clinical implicationsEric J Vick, Daniel T Starczynowski
The Journal of Experimental Medicine|June 15, 2021
Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDSJennifer J Trowbridge, Daniel T Starczynowski
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Blood|August 2, 2014
Errant innate immune signaling in del(5q) MDSDaniel T Starczynowski
Blood|October 1, 2020
HHEX expression drives AML developmentDaniel T Starczynowski
Haematologica|June 15, 2023
Are <i>DDX41</i> variants of unknown significance and pathogenic variants created equal?Zhuoer Xie, Daniel T Starczynowski
Cell Stem Cell|May 6, 2017
GMP-ing to Spatial Conclusions about Emergency and Leukemic MyelopoiesisMadeline Niederkorn, Daniel T Starczynowski
Cell Cycle (Georgetown, Tex.)|February 18, 2010
Deregulation of innate immune signaling in myelodysplastic syndromes is associated with deletion of chromosome arm 5qDaniel T Starczynowski, Aly Karsan
Hematology/Oncology Clinics of North America|April 3, 2010
Innate immune signaling in the myelodysplastic syndromesDaniel T Starczynowski, Aly Karsan
Molecular & Cellular Oncology|June 17, 2016
Genomic instability establishes dependencies on acquired gene regulatory networks: A novel role of p62 in myeloid malignancies with del(5q)Jing Fang, Daniel T Starczynowski
Current Opinion in Hematology|November 7, 2021
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignanciesJoshua Bennett, Daniel T Starczynowski
Expert Opinion on Investigational Drugs|October 10, 2025
IRAK signaling in cancers: mechanisms, targeting, and clinical implicationsEric J Vick, Daniel T Starczynowski
The Journal of Experimental Medicine|June 15, 2021
Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDSJennifer J Trowbridge, Daniel T Starczynowski
Pageof 10